Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer in Head & Neck, Lung, Oesophagus, Anal Canal and Uterine Cervix - a Basis for Personalised Radiotherapy

NCT02379039 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.

NCT NCT02379039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02379039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer in Head & Neck, Lung, Oesophagus, Anal Canal and Uterine Cervix - a Basis for Personalised Radiotherapy
Lead sponsor
Umeå University
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
May 31, 2023
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, cervix cancer, esophageal cancer, head and neck cancer, lung cancer, squamous carcinoma